evolocumab
US/ˌɛv.əˈlɑk.jəˌmæb/
evolocumab noun: a human monoclonal antibody designed for the treatment of hyperlipidemia.
Noun
evolocumab (uncountable)
- A human monoclonal antibody designed for the treatment of hyperlipidemia.
- So was Repatha, or evolocumab, a similar drug developed by Amgen that is expected to win F.D.A. approval by the end of August.2015 July 24, Andrew Pollack, “New Drug Sharply Lowers Cholesterol, but It’s Costly”, in New York Times
Origin of evolocumab
From [Term?] + -c- (“cardiovascular”) + -umab (“human monoclonal antibody”).
Questions about evolocumab
- What does evolocumab mean?
- Evolocumab means a human monoclonal antibody designed for the treatment of hyperlipidemia.
- What part of speech is evolocumab?
- Evolocumab is a noun.
- How do you pronounce evolocumab?
- Evolocumab is pronounced /ˌɛv.əˈlɑk.jəˌmæb/ (US).
Words near evolocumab in the dictionary
Source and license
Adapted from Wiktionary: evolocumab (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “evolocumab.” Word.ws, https://word.ws/evolocumab. Based on Wiktionary, CC BY-SA 4.0.
